PRMT5, a type II arginine methyltransferase, dimethylates arginine residues symmetrically. Its functions extend into T cell development, B cell regulation, hematopoiesis, and mitotic control. Recently, it has also been implicated in aspects of innate immunity via both its traditional role and inhibition of viral replication by a non-arginine methyltransferase modality.
PRMT5 acts to suppress the cGAS/STING pathway in the cytoplasm via dimethylation of the cytosolic cGAS Arg124 residue, blocking its cytosolic DNA binding abilities. In macrophages, PRMT5 has been shown to associate with nuclear Carbonic Anhydrase 6B (CA VI-B) to upregulate the expression of the pro-inflammatory cytokine IL-12 in an innate response to intracellular bacterial infection. PRMT5 is shown to have a profound antiviral effect on Hepatitis B (HBV) infection.
Read more about PRMT5 as a therapeutic target in this article: PRMT5 is Innately Interesting